Clinical Trial Update: Voyage: Real-World Impact of the Multi-target Stool DNA Test on CRC Screening and Mortality

View source ↗

Summary

Real-world data from the Voyage study evaluates the impact of Exact Sciences' multi-target stool DNA test on colorectal cancer screening and mortality.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cologuard (multi-target stool DNA test for colorectal cancer)

Snippet

Sponsor: Exact Sciences Corporation | Conditions: Colon Cancer | Status: ACTIVE_NOT_RECRUITING